Interestingly, treatment of BCL6-expressing Burkitt lymphoma cells and Burkitt lymphoma xenograft mice with a dual SIRT1 and SIRT2 inhibitor, cambinol, produced a potent antitumor effect [39]. The gene discussed is SIRT1; the disease is Burkitt lymphoma.